Figure 4.
Management of anticoagulant therapy in cancer patients. VKA: vitamin K antagonist; NOAC: new oral anticoagulant; LMWH: low-molecular-weight heparin.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.